Nasdaq(NDAQ)
Search documents
Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
Benzinga· 2024-10-31 18:43
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping around 500 points on Thursday.The Dow traded down 0.62% to 41,880.03 while the NASDAQ fell 2.69% to 18,107.65. The S&P 500 also fell, dropping, 1.64% to 5,718.50.Check This Out: Top 2 Real Estate Stocks You May Want To Dump This QuarterLeading and Lagging SectorsUtilities shares rose by 1.6% on Thursday.In trading on Thursday, information technology shares fell by 3.4%.Top HeadlineShares of Uber Technologies, Inc UBER dipp ...
23andMe Regains Compliance With Nasdaq Listing Requirements
GlobeNewswire News Room· 2024-10-30 21:00
SUNNYVALE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the "Company" or "23andMe"), a leading human genetics and preventive health company, today announced that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2) and the majority independent board and various board committee requirements under Nasdaq Listing Rule 5605. Accordingly, the Company's Class A common stock will continue to be listed on The Nasdaq Ca ...
S&P500 and Nasdaq Index: Cloud Gains Lift Alphabet, but AMD Drags on Market
FX Empire· 2024-10-30 17:39
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Nasdaq, Dow Jones and S&P 500 Forecast – US Indices Continues to Churn
FX Empire· 2024-10-30 14:11
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Prnewswire· 2024-10-30 10:00
NEW YORK, Oct. 30, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced that on October 29, 2024, the Company received written notice from The Nasdaq Stock Market stating that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market.Accordingly, the Company's common stock will continue to ...
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
GlobeNewswire News Room· 2024-10-30 01:05
GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced the pricing of its "reasonable best efforts" public offering with a health-care focused institutional investor for the purchase and sale of up to 2,950,820 shares of common stock (or pre-funded warr ...
Nasdaq(NDAQ) - 2024 Q3 - Quarterly Report
2024-10-29 15:12
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number: 001-38855 ___________________________________ Nasdaq, Inc. (Exact name of registrant as ...
Terrifier 3's Art the Clown to Ring Nasdaq Closing Bell as Cineverse Celebrates Halloween - and the Killer Box Office Success of its Hit Indie Slasher Film
Prnewswire· 2024-10-29 13:30
NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Cineverse (Nasdaq: CNVS), an innovative streaming entertainment and technology company, will visit the Nasdaq MarketSite in Times Square on October 31, 2024.To celebrate the recent box office success of independent slasher hit movie, Terrifier 3— distributed by Cineverse — the company has asked the film's iconic character Art the Clown to ring the Closing Bell.Also joining him on Halloween will be Cineverse executives and guests, including representatives from Terrifi ...
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Prnewswire· 2024-10-29 12:30
GAITHERSBURG, Md., Oct. 29, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has received a written notice (the "Compliance Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") dated October 21, 20 ...
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire News Room· 2024-10-29 12:00
SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive agreements for the purchase and sale of 745,342 shares of the Company's common stock at an offering price of $4.025 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase ...